Patent · US Active

Oncolytic rhabdovirus

US8481023B2 · kind B2 · utility

0Cited by

47References

4Claims

0Family size

Assignee

Ottawa Hospital Research Institute · CA

Inventors

David F. Stojdl · Ottawa, CA
Christopher Brown · Edina, US
John Bell · Ottawa, CA

Key dates

Filing date	Sep 17, 2007
Grant date	Jul 9, 2013
Priority date	—
Expiry date	Oct 25, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2810/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments of the invention include compositions and methods related to non-VSV rhabdoviruses and their use as anti-cancer therapeutics. Such rhabdoviruses possess tumor cell killing properties in vitro and in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.